Jul 25,2017

DarioHealth Partners with Byram Healthcare to Further Expand Insurance Health Coverage for U.S. Consumers

DarioHealth Corp. today announced that it is expanding its insurance coverage provider network by entering into a strategic agreement with New York-based Byram Healthcare. Byram is a market-leading distributor of reimbursable medical supplies to home patients and home health agencies in the United States. As reported last month, DarioHealth expanded its 3rd party insurance coverage option for U.S. consumers who want their DarioHealth products reimbursed by insurance. With the addition of Byram Healthcare, DarioHealth expects to cover 30% of consumers in the U.S. diabetes market. In just a few months since launching the insurance health coverage initiative, DarioHealth has received feedback, and covered major insurance plans, such as Aetna, United HealthCare, and various Blue Cross Blue Shield programs.

COLLABORATION PARTNERSHIP

#institution

#bgm

#mobile app

View Analyst & Ambassador Comments
Go to original news
Aug 15,2017

Nemaura Signs Heads of Terms for sugarBEAT® with Device Technologies for Australia and New Zealand

Nemaura Medical Inc., a medical technology company focused on the development and commercialization of sugarBEAT® announced today it has signed a non-binding term sheet with Device Technologies for exclusive rights to market and sell sugarBEAT® in Australia and New Zealand. Nemaura Medical expect to launch in Australia and New Zealand in 2018, following an anticipated initial launch in UK in 2017.

COLLABORATION PARTNERSHIP

#institution

#cgm

View Analyst & Ambassador Comments
Go to original news
Oct 07,2017

App way to manage gestational diabetes

Doctors at the National University Hospital (NUH) hope that a mobile app, which can track a patient's weight and blood glucose levels, can help pregnant women with gestational diabetes. NUH is now conducting clinical trials with Jana Care. The trial was started last month and has involved 20 women with gestational diabetes. The goal is to recruit 340 in the next 10 months. Half the participants will use the app as well as a special weighing scale, and the rest will be in a control group.

COLLABORATION PARTNERSHIP

#institution

#mobile app

View Analyst & Ambassador Comments
Go to original news
Nov 16,2017

First Made-in-India 'Digital Pill' by Wellthy Therapeutics to Undergo Clinical Trial for Diabetes

The #WeDiDiT (Wellthy Digital Diabetes Therapy) trial is all set to prove the efficacy of its 16-week structured diabetes management programme delivered through a mobile app. The trial was launched by Past President of RSSDI, Dr. Sarita Bajaj at the RSSDI Annual Conference in Bhubaneswar in the first week of November. The outcome of this multi-center randomized control trial will be measured by the HbA1C levels of patients before and after the trial.

COLLABORATION PARTNERSHIP

#institution

View Analyst & Ambassador Comments
Go to original news
Jan 25,2016

Fit4D (now named as Cecelia Health) Launches with Acacia Health Network

Fit4D (now named as Cecelia Health) announced today that it launched its innovative diabetes platform to members of Acacia Network’s Integrated Service Delivery System. Acacia Network is the second largest Latino non-profit in the country and its network of integrated services provides care for a largely underserved Latino population in NYC, Albany and Buffalo, NY.

COLLABORATION PARTNERSHIP

#institution

View Analyst & Ambassador Comments
Go to original news
Jul 21,2016

LabStyle Innovations Corp. Executes Distribution Partnership with GEMCO Medical

LabStyle Innovations Corp., developer of the Dario™ Blood Glucose Monitoring System, announced today that it has signed an agreement with GEMCO Medical, an established healthcare distributor and a pioneer in the diabetes supply industry, to become the first authorized U.S. distributor of Dario. This partnership will complement LabStyle's direct-to-consumer model to further expand and strengthen its presence in the United States.

COLLABORATION PARTNERSHIP

#institution

#mobile app

#bgm

View Analyst & Ambassador Comments
Go to original news
Sep 02,2016

Nemaura Medical Inc., sign Letter of Intent with Shenzen CAS Health Corp, for potential JV and manufacture of their sugarBEAT® system

Nemaura Medical Inc., a medical device company developing a minimally invasive, needle-free, wireless CGM patch known as sugarBEAT®, today announced that it has signed a letter of intent (LOI) with a Chinese Corporation, Shenzen CAS Health Corporation Limited, which is a partially owned subsidiary of the Chinese Academy of Science. The letter of intent covers three potential joint venture arrangements relating specifically to sugarBEAT® including (a) setting up a joint venture company to distribute in China, (b) setting up a manufacturing facility in China and (c) obtaining CFDA approval.

COLLABORATION PARTNERSHIP

#institution

#cgm

View Analyst & Ambassador Comments
Go to original news
Oct 20,2016

Health2Sync partners with Taiwan's MOHW to launch online diabetes care program

Health2Sync partners with Taiwan’s Ministry of Health and Welfare in Asia’s first government supported online diabetes care program. Since September 2016, MOHW and Health2Sync together have enabled more than 30 hospitals and clinics to provide real-time tracking and immediate feedback to patients. Health2Sync's hardware-agnostic software reduces the cost and time to administer remote diabetes care significantly, enabling diabetes care to scale quickly and effectively.

COLLABORATION PARTNERSHIP

#institution

#mobile app

#rpm

View Analyst & Ambassador Comments
Go to original news
Nov 10,2016

BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company today announced a new research collaboration supported by JDRF, the leading global organization funding type 1 diabetes (T1D) research. The collaboration expands the commitment from JDRF and BD to explore new advancements in therapy options for people with type 1 diabetes. This new, two-year funding commitment from JDRF will enable BD to focus on technology enhancements to support the development of an extended wear insulin infusion set.

COLLABORATION PARTNERSHIP

#institution

View Analyst & Ambassador Comments
Go to original news
Nov 11,2015

LabStyle Innovations' Dario Diabetes Management Solution to Launch in India Through Distribution Agreement with Centaur Pharmaceuticals

LabStyle Innovations Corp., developer of the Dario™ Diabetes Management Solution, announced today that it has signed an exclusive distribution agreement with one of India's leading pharmaceutical and medical device networks, Centaur Pharmaceuticals Pvt. Ltd. As one of India's top ranked healthcare companies, Centaur's network includes a sales force of 1,000 covering 250,000 doctors and 250,000 retailers.

COLLABORATION PARTNERSHIP

#institution

#mobile app

#bgm

View Analyst & Ambassador Comments
Go to original news
Subscribe to INSTITUTION